Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study.
Saved in:
| Title: | Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study. |
|---|---|
| Authors: | Bazzichi L; AOU Pisana Ospedale Santa Chiara, Pisa. l.bazzichi@gmail.com., Biasi D, Tinazzi E, Muratore M, Pellerito R, Russo R, Corsaro Santi M, De Sandre P, Epis O, Granata M, Kroegler B, Meschini C, Versace F, Astolfi C |
| Corporate Authors: | RUBINO study group |
| Source: | Reumatismo [Reumatismo] 2014 Nov 06; Vol. 66 (3), pp. 224-32. Date of Electronic Publication: 2014 Nov 06. |
| Publication Type: | Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: PagePress Country of Publication: Italy NLM ID: 0401302 Publication Model: Electronic Cited Medium: Internet ISSN: 0048-7449 (Print) Linking ISSN: 00487449 NLM ISO Abbreviation: Reumatismo Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
